2-(4-Ethylpiperazin-1-yl)-6-nitro-3-phenylquinazolin-4(3H)-one

ID: ALA3344455

PubChem CID: 60156248

Max Phase: Preclinical

Molecular Formula: C20H21N5O3

Molecular Weight: 379.42

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCN1CCN(c2nc3ccc([N+](=O)[O-])cc3c(=O)n2-c2ccccc2)CC1

Standard InChI:  InChI=1S/C20H21N5O3/c1-2-22-10-12-23(13-11-22)20-21-18-9-8-16(25(27)28)14-17(18)19(26)24(20)15-6-4-3-5-7-15/h3-9,14H,2,10-13H2,1H3

Standard InChI Key:  CTGFEMFIPBZNLC-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 28 31  0  0  0  0  0  0  0  0999 V2000
    0.7456   -2.0883    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7445   -2.9079    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4525   -3.3168    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4507   -1.6795    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1593   -2.0847    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1627   -2.9099    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8751   -3.3173    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5887   -2.9041    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5853   -2.0789    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8683   -1.6669    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8638   -0.8498    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.2975   -3.3107    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.2917   -1.6681    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0371   -1.6802    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6750   -2.0889    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0369   -0.8630    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9999   -2.0766    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7059   -1.6665    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7038   -0.8484    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9899   -0.4422    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2868   -0.8546    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2966   -4.1281    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0014   -4.5347    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7104   -4.1277    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.7101   -3.3095    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0008   -2.8984    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4176   -4.5370    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4168   -5.3542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  5 10  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
  8 12  1  0
  9 13  1  0
 14 15  2  0
 14 16  1  0
  1 14  1  0
 13 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 13  1  0
 12 22  1  0
 12 26  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 24 27  1  0
 27 28  1  0
M  CHG  2  14   1  16  -1
M  END

Associated Targets(non-human)

Venezuelan equine encephalitis virus (381 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 379.42Molecular Weight (Monoisotopic): 379.1644AlogP: 2.44#Rotatable Bonds: 4
Polar Surface Area: 84.51Molecular Species: NEUTRALHBA: 7HBD:
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.55CX LogP: 3.06CX LogD: 2.68
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.51Np Likeness Score: -1.79

References

1. Schroeder CE, Yao T, Sotsky J, Smith RA, Roy S, Chu YK, Guo H, Tower NA, Noah JW, McKellip S, Sosa M, Rasmussen L, Smith LH, White EL, Aubé J, Jonsson CB, Chung D, Golden JE..  (2014)  Development of (E)-2-((1,4-dimethylpiperazin-2-ylidene)amino)-5-nitro-N-phenylbenzamide, ML336: Novel 2-amidinophenylbenzamides as potent inhibitors of venezuelan equine encephalitis virus.,  57  (20): [PMID:25244572] [10.1021/jm501203v]

Source